SUMMARY:
Hepatitis C virus (HCV) core and envelope proteins are suggested to be responsible for the pathogenesis of hepatic and extrahepatic manifestations in chronic hepatitis C. Moreover, the core protein is implicated in the regulation of the transcription of cellular genes including c-myc, RB and p53. Determining the subcellular localization of the core and envelope proteins is therefore necessary to elucidate their behaviors, particularly in vivo ones, regarding the interaction with transcriptional regulatory proteins or gene elements. We defined the subcelluar localization of HCV envelope and core proteins which were expressed in substantial levels in the liver of transgenic mice. Subcellular fractionation by ultra-centrifugation revealed that the envelope proteins were present principally in the microsomes of the liver, while a small amount of the protein was detected also in the nuclei. Immunohistochemistry confirmed the localization of envelope proteins in the nuclei. In contrast, the core protein was detected principally in the cytoplasmic fraction, where it was closely associated with lipids. A low level of the core protein was detected also in the nuclei and microsomal fraction. Recently, the HCV envelope proteins have been shown to be responsible for the pathogenesis of sialadenitis resembling Sjogren syndrome (12) which has been reported to be observed in patients with chronic hepatitis C (13). On the other hand, the HCV core protein has been implicated in the regulation of the transcription of cellular genes including c-myc (14) and RB (15) . The core gene has also been suggested to be involved in the transformation of fibroblasts in collaboration with the H-ras oncogene (16) and in the sensitization of cells to apoptotic signals (17) . A recent work using transgenic mice has revealed that the core protein induces hepatic steatosis (18) , which is one of the histopathological features of chronic hepatitis C (19, 20) . Studying the localization of these HCV structural proteins is therefore important for understanding their roles, particularly in vivo ones in modifying gene transcription or protein interaction. In this study, we determined the subcellular localization of the HCV envelope and core proteins in the liver of transgenic mice.
The production of HCV envelope gene-and HCV core gene-transgenic mice has already been described (9, 18) . In mice of the envelope gene transgenic mouse lines, E 101 and E139, the envelope proteins, E 1 and E2, were expressed in the liver, and the core protein in the mouse liver of the core gene transgenic mouse lines, C21 and C49, as detected by Western blotting. In the present study, mice from the envelope and core transgenic mouse lines were analyzed. previously (9) . The filter was then allowed to react with anti-core, anti-El or anti-E2 monoclonal antibody, followed by anti-mouse IgG conjugated with horse radish peroxidase (Vector Labs.) and proteins were visualized with an ECL kit (Amersham Intl., Buckinghamshire, UK).
In the liver of the envelope gene transgenic mice, both the E1 and E2 proteins were detected chiefly in the microsomal fraction, while a small amounts of both proteins were detected also in the nuclear fraction as 35 and 58 kDa proteins, respectively (Fig. 1) . Localization of the envelope proteins in the nuclei was confirmed also by immunohistochemistry. Figure 2A shows a representative micrograph of the localization of the E2 protein, in which the nuclei of hepatocytes around the central vein exhibited darker staining than those in other areas, demonstrating the localization of the E2 protein in the nuclei. Control mouse liver was not stained with anti-E2 rabbit serum, nor was transgenic mouse liver with normal rabbit serum ( Fig. 2B and C) . We then carried out Western blot analysis on the samples that were processed for subcellular fractionation. Because the HCV core protein had been shown to be associated with lipid droplets in cells by immunohistochemistry (18, 22) , the lipid layer in the cytosol fraction was analyzed separately. As we expected, a substantial level of the core protein was detected in the lipid layer which was separated as an upper phase of the cytosol fraction (Fig. 3) . A low level of expression of the core protein was detected also in the nuclear and microsomal fraction. The localization of the core protein in the nuclei was confirmed also by immunoelectron microscopy (data not shown).
In our analysis of the structural proteins of HCV that are expressed in the liver of living animals, both the core and envelope proteins (E1 and E2) were detected in the hepatocytic nuclei, while the majority of the core protein in the lipid layer in the cytosol fraction and the envelope proteins in the microsomal fraction. These results are partly consistent with the findings in HCV transgenic mouse lines reported by other researchers. In one HCV core gene transgenic mouse line, when liver tissue was separated into the nuclear and cytoplasmic fractions by simple ultracentrifugation, the core protein was detected in the latter fraction (10) . However, it is not clear whether the core protein is associated with lipids since the authors did not mention the occurrence of lipid accumulation in their transgenic mouse liver. A possible problem with their study is that the existence of the core protein was demonstrated by Western blotting only with human sera from chronic hepatitis C patients, whereas the HCV core protein has been reported to be readily detectable with monoclonal antibodies (11, 18, 23, 24) . Splicing of RNA transcribed from the cDNA of the HCV genome might be a cuase of an obstacle in the expression of the viral proteins in transgenic mice. In another study, Kawamura et al. (11) using immunohistochemistry reported that the core protein was present chiefly in the cytoplasm but was detected also in the nuclei of some hepatocytes. However, their result is not conclusive because further study including subcellular localization analysis was not carried out. Kawamura et al. (11) reproted also that the E2 protein was detected in the cytoplasm by immunohistochemical analysis although the staining was equivocal . In both reports, low levels of expression of the proteins may have hampered the localization analysis of these proteins. This may also account for the absence of steatosis in the liver of their core gene transgenic mice, although the observation periods were short, which phenotype has been described in mice exhibiting unambiguous expression of the core protein (18) . It is notable that the levels of the core protein in our transgenic mice are comparable to those in the liver from patients with 
